- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 37.56M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 37.71M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 37.41M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $0 |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $1.01M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $5.15M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $5.32M |
| Capex | Q1 2026 · Mar 31, 2026 | $2.77M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $8.05M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $26.2M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $10.13M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $291.91M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $311.21M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $39.45M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $34.6M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $44.59M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $40.51M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $288.88M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $294.23M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $277.42M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $277.51M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $182.26M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $169.01M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $547.86M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $558.35M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $300.03M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $281.46M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $836.73M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $852.58M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.05 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.18 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.05 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.18 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $28M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $29.29M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.83M |
| Net Income | Q1 2026 · Mar 31, 2025 | $6.81M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $24.85M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $17.2M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $56.55M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $50.22M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $108.04M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $111.45M |
| Revenue | Q1 2026 · Mar 31, 2026 | $164.58M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $161.67M |